Brown Brothers Harriman & Co. »

Prime Medicine shares owned by Brown Brothers Harriman & Co.

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Brown Brothers Harriman & Co. from 13F filings

Historical chart of Brown Brothers Harriman & Co. investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Brown Brothers Harriman & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Brown Brothers Harriman & Co.

Quarter filed Position value Share count Share price at filing
2023-12-31 $89k 10k 8.86
2023-09-30 $96k 10k 9.54
2023-06-30 $148k 10k 14.65

More positions owned by Brown Brothers Harriman & Co.

Berkshire Hathaway Inc-cl B Common Stock (BRK.B)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-cl C Common Stock (GOOG)
Linde Common Stock (LIN)
Mastercard Inc - A Common Stock (MA)
Zoetis Common Stock (ZTS)
Waste Management Common Stock (WM)
Oracle Corp Common Stock (ORCL)
Kla Corp Common Stock (KLAC)
Progressive Corp Common Stock (PGR)
Arthur J Gallagher & Co Common Stock (AJG)
Alcon Common Stock (ALC)
Amazon.com Common Stock (AMZN)
Booking Holdings Common Stock (BKNG)
Thermo Fisher Scientific Common Stock (TMO)

View all positions for Brown Brothers Harriman & Co.

Top funds holding Prime Medicine

Alphabet
ARK Investment Management
Vanguard Group
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
T. Rowe Price Associates
Redmile Group
Baker Bros. Advisors
Deerfield Management Company
Greenwich Wealth Management
Bank of America Corporation
Samsara BioCapital
Casdin Capital
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Prime Medicine